Working… Menu

Phase I Trial to Determine the Safety and Pharmacokinetics of CRS3123.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02106338
Recruitment Status : Completed
First Posted : April 8, 2014
Last Update Posted : June 13, 2016
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)